Open rings of demyelination – a rare case of tumefactive multiple sclerosis

Authors

  • Parameswaran K. Department of Internal Medicine, SRM Medical College Hospital and Research Center, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India https://orcid.org/0009-0008-1722-6379
  • Nemani Sai Manasa Department of Internal Medicine, SRM Medical College Hospital and Research Center, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India https://orcid.org/0009-0000-3696-3990
  • Nirmala Devi Chandrasekaran Department of Internal Medicine, SRM Medical College Hospital and Research Center, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India https://orcid.org/0000-0002-1122-5016
  • C. Aswin Department of Internal Medicine, SRM Medical College Hospital and Research Center, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India
  • J.S. Kumar Department of General Medicine, SRM Medical College Hospital and Research Center, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India
  • Dev Sudersan Venkatesan Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India https://orcid.org/0000-0001-9662-5459
  • Dhivakar Ramalingam Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India https://orcid.org/0009-0000-0841-8936

DOI:

https://doi.org/10.15584/ejcem.2025.3.10

Keywords:

case report, demyelination, neuroimaging, open ring-enhancing lesion, stroke mimic, tumefactive MS

Abstract

Introduction and aim. Tumefactive multiple sclerosis (MS), a rare and atypical subtype of MS, presents with large demyelinating lesions that can mimic acute stroke, leading to diagnostic uncertainty. Stroke-like symptoms in such cases require a thorough neuroimaging. We describe the case of a 35-year-old woman who presented with acute onset of right-sided hemiparesis and hemisensory loss, along with facial weakness of the left upper motor neuron facial weakness and focal seizures. Initially suspected to be a cerebrovascular event, the condition was later diagnosed as tumefactive multiple sclerosis.

Description of the case. Comprehensive neurological assessment with neuroimaging and magnetic resonance peduncle, and bilateral cerebral hemispheres, raising suspicion of a demyelinating process. A differential diagnosis, including neoplastic, infectious, and inflammatory conditions was carefully evaluated before confirming tumefactive MS. The patient’s stroke-like deficits improved significantly with high-dose intravenous methylprednisolone therapy. Follow-up imaging demonstrated the resolution of the enhancing lesions, strengthening the diagnosis. The dramatic response to steroids and the absence of progressive deterioration helped differentiate tumefactive MS from gliomas or infectious abscesses.

Conclusion. This case highlights the importance of considering tumefactive MS in acute neurological deficits with ring-enhancing lesions. Advanced imaging techniques are crucial for accurate differentiation that allows for timely and appropriate treatment.

Downloads

Download data is not yet available.

References

Peker E, Ünal S, Uludağ SB, Zorlu NSY. Ring-Enhancing Lesions-Differentiation with MRI. Br J Hosp Med (Lond). 2024;85(10):1-20. doi:10.12968/hmed.2024.0195

Fereidan-Esfahani M, Decker PA, Eckel Passow JE, Lucchinetti CF, Flanagan EP, Tobin WO. Population-based incidence and clinical-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States. Eur J Neurol. 2022;29(3):782-789. doi:10.1111/ene.15182

Al Malik YM. Tumefactive demyelinating lesions: A literature review of recent findings. Neurosciences Journal. 2024;29(3):153. doi:10.17712/nsj.2024.3.20230111

Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-86. doi:10.1212/wnl.0000000000000560

Tosunoğlu B, Gökçe ÇB, Nalan GH, Nilay K, and Yoldaş TK. Tumefactive multiple sclerosis. Baylor University Medical Center Proceedings. 2024;37(2):344-347. doi: 10.1080/08998280.2023.2289301

Balloy G, Pelletier J, Suchet L, et al. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients. J Neurol. 2018;265(10):2251-2259. doi: 10.1007/s00415-018-8984-7

Zaheer K, Ajmeri AN, Singh M, Suliman MS, Teka S. Tumefactive Multiple Sclerosis, A Rare Variant Presenting as Multiple Ring-enhancing Lesions in an Immunocompetent Patient: A Case Report. Cureus. 2018;10(12):e3738. doi: 10.7759/cureus.3738

ElSaygh J, Kandinova N, Zaher A, Sunner GK, Kostanyan S. Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities. Cureus. 2023;15(7):e41845. doi: 10.7759/cureus.41845

Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: A comprehensive review. Mult Scler Relat Disord. 2017;14:72-79. doi: 10.1016/j.msard.2017.04.003

Nakayama M, Naganawa S, Ouyang M, et al. A Review of Clinical and Imaging Findings in Tumefactive Demyelination. AJR Am J Roentgenol. 2021/07/01 2021;217(1):186-197. doi:10.2214/AJR.20.23226

Altintas A, Petek B, Isik N, et al. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study. Mult Scler. 2012;18(10):1448-1453. doi: 10.1177/1352458512438237

French HD. Tumefactive multiple sclerosis versus high-grade glioma: A diagnostic dilemma. Surg Neurol Int. 2021;12:199. doi: 10.25259/sni_901_2020

Fereidan-Esfahani M, Tobin WO. Cyclophosphamide in treatment of tumefactive multiple sclerosis. Mult Scler Relat Disord. 2021;47. doi:10.1016/j.msard.2020.102627

Downloads

Published

2025-09-30

How to Cite

K., P., Manasa, N. S., Chandrasekaran, N. D., Aswin, C., Kumar, J., Venkatesan, D. S., & Ramalingam, D. (2025). Open rings of demyelination – a rare case of tumefactive multiple sclerosis. European Journal of Clinical and Experimental Medicine, 23(3), 809–812. https://doi.org/10.15584/ejcem.2025.3.10

Issue

Section

CASE REPORTS